We are monitoring the impact of COVID-19 on Europe Nuclear Medicine Radiopharmaceuticals Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 106
Share on
Share on

Europe Nuclear Medicine Radiopharmaceuticals Market Research Report - By Diagnostics, Therapeutics, Application, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic And Rest Of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2019-2024)

Pulished: August, 2019
ID: 106
Pages: 145

Europe Nuclear Medicine Radiopharmaceuticals Market Size & Growth (2019 - 2024)

Europe's market for Nuclear Medicine Radiopharmaceuticals is estimated at $1.52 billion in 2019 and is expected to reach $2.6 billion by 2024, growing at a CAGR of 11.4%.

The rise in the demand to improve diagnostic and treatment procedures is considered to be a major factor leveling up the demand of the market. A growing number of people suffering from chronic and cardiovascular problems is another factor driving the demand of the market in Europe. Also, the emergence of new applications in radiopharmaceuticals with advanced technology is greatly influencing the demand of the market. Escalating expenditure on healthcare is additionally propelling the growth of the nuclear medicine radiopharmaceuticals market in Europe. The rise in the demand for targeted treatment procedures is accelerating the growth rate of the market.

However, stringent rules and regulations by government authorities in approving new products are quietly hindering the demand of the market. Cost for installation and maintenance of the equipment in clinical laboratories need huge amounts where small scale enterprises cannot afford remains as a challenging factor for the market players. Rising complications with the regular usage of the drugs in some patients are impeding the growth rate of the Europe nuclear medicine radiopharmaceuticals market.

Increasing disposable income in urban areas is straightly expanding the demand for this market. Growing support from the government and non-government organizations through funds on developing nuclear medicine with high quality is setting up growth opportunities for the market in Europe. Rise in the awareness over the availability of various treatment procedures among people is elevating the growth rate of this market. On-going research on developing new treatment procedures for various diseases at low cost is lavishing the demand of the nuclear medicine radiopharmaceuticals market in Europe.

This research report segmented and sub-segmented into the following categories:

Europe Nuclear Medicine Radiopharmaceuticals Market -By Type:

  • Diagnostic Radioisotopes                 

    • SPECT    

      • Technetium-99m

      • Thallium-201

      • Gallium-67

      • Iodine-23

      • Others

    • PET         

      • Fluorine-18

      • Rubidium-82

      • Others

  • Therapeutic Radioisotopes                              

    • Beta Emitters     

      • Iodine-131

      • Yttrium-90

      • Samarium-153

      • Rhenium-186

      • Lutetium-177

    • Alpha Emitters   

      • Radium-223

    • Brachytherapy   

      • Cesium-131

      • Iodine-125

      • Palladium-103

      • Iridium-192

Europe Nuclear Medicine Radiopharmaceuticals Market - By Application:

  • Cardiology                               

  • Lymphoma                             

  • Thyroid                     

  • Neurology               

  • Oncology                 

  • Others    

By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe.

Regionally, Europe is growing at a faster rate from the past decade and is also to grow at a CAGR of 8.2% during the forecast period. Germany is holding the highest shares of the market with a rise in capital income. Besides, the adoption of the latest technological developments in the clinical centers is leveraging the growth rate of the market. Following Germany, U.K and France are leading to dominant shares of the market. Rise in the awareness over SPECT and PET diagnostic procedures for accurate results is fueling the growth of the nuclear medicine radiopharmaceuticals market. Increasing concern towards health and people demand effective diagnostic and treatment procedures is prompting the demand for this market. Italy, Spain, Russia and the Rest of Europe are anticipated to have a significant growth rate in foreseen years with the growing investments in the hospitals and diagnostic centers.

Leading companies in the market

Prominent companies operating in the Europe nuclear medicine Radiopharmaceuticals Market profiled in the report are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation, Positron Corporation, Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and BA Molecular Imaging.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                            

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                     

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type                                        

                                5.1.1 Diagnostic Radioisotopes                 

                                                5.1.1.1 SPECT    

                                                                5.1.1.1.1 Technetium-99m

                                                                5.1.1.1.2 Thallium-201

                                                                5.1.1.1.3 Gallium-67

                                                                5.1.1.1.4 Iodine-23

                                                                5.1.1.1.5 Others

                                                5.1.1.2 PET         

                                                                5.1.1.2.1 Fluorine-18

                                                                5.1.1.2.2 Rubidium-82

                                                                5.1.1.2.3 Others

                                5.1.2 Therapeutic Radioisotopes                              

                                                5.1.2.1 Beta Emitters     

                                                                5.1.2.1.1 Iodine-131

                                                                5.1.2.1.2 Yttrium-90

                                                                5.1.2.1.3 Samarium-153

                                                                5.1.2.1.4 Rhenium-186

                                                                5.1.2.1.5 Lutetium-177

                                                5.1.2.2 Alpha Emitters   

                                                                5.1.2.2.1 Radium-223

                                                5.1.2.3 Brachytherapy   

                                                                5.1.2.3.1 Cesium-131

                                                                5.1.2.3.2 Iodine-125

                                                                5.1.2.3.3 Palladium-103

                                                                5.1.2.3.4 Iridium-192

                5.2 By Application                                           

                                5.2.1 Cardiology                               

                                5.2.2 Lymphoma                             

                                5.2.3 Thyroid                     

                                5.2.4 Neurology               

                                5.2.5 Oncology                 

                                5.2.6 Others                      

6. Geographical Analysis                                                              

                6.1 Introduction                                              

                6.2 U.K                                

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8.Market Leaders' Analysis                                                          

                8.1 GE Healthcare                                           

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Hologic Inc.                                

                8.3 Segami Corporation                                

                8.4 Positron Corporation                                              

                8.5 Bracco Imaging S.P.A                                              

                8.6 Naviscan Inc.                                              

                8.7 Bayer Healthcare                                     

                8.8 Lantheus Medical Imaging Inc.                                           

                8.9 IBA Molecular Imaging                                           

                8.10 Medix Inc.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10.Expert Opinions                                                         

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Nuclear Medicine Radiopharmaceuticals Market By Region, From 2019-2024 (USD Million)
  2. Europe Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  3. Europe Diagnostic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  4. Europe Therapeutic Radioisotopes Market By Region, From 2019-2024 (USD Million)
  5. Europe Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  6. Europe Cardiology Market By Region, From 2019-2024 (USD Million)
  7. Europe Lymphoma Market By Region, From 2019-2024 (USD Million)
  8. Europe Thyroid Market By Region, From 2019-2024 (USD Million)
  9. Europe Neurology Market By Region, From 2019-2024 (USD Million)
  10. Europe Oncology Market By Region, From 2019-2024 (USD Million)
  11. Europe Other Applications Market By Region, From 2019-2024 (USD Million)
  12. Europe Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  13. Europe SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  14. Europe PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  15. Europe Other Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  16. Europe SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  17. Europe Technetium-99m Market By Region, From 2019-2024 ( USD Million )
  18. Europe Thallium-201 Market By Region, From 2019-2024 ( USD Million )
  19. Europe Gallium-67 Market By Region, From 2019-2024 ( USD Million )
  20. Europe Iodine-23 Market By Region, From 2019-2024 ( USD Million )
  21. Europe Other SPECT Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  22. Europe PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  23. Europe Fluorine-18 Market By Region, From 2019-2024 ( USD Million )
  24. Europe Rubidium-82 Market By Region, From 2019-2024 ( USD Million )
  25. Europe Other PET Diagnostic Radioisotopes Market By Region, From 2019-2024 ( USD Million )
  26. Europe Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  27. Europe Beta Emitters Market By Region, From 2019-2024 ( USD Million )
  28. Europe Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  29. Europe Brachytherapy Market By Region, From 2019-2024 ( USD Million )
  30. Europe Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  31. Europe Iodine-131 Market By Region, From 2019-2024 ( USD Million )
  32. Europe Yttrium-90 Market By Region, From 2019-2024 ( USD Million )
  33. Europe Samarium-153 Market By Region, From 2019-2024 ( USD Million )
  34. Europe Rhenium-186 Market By Region, From 2019-2024 ( USD Million )
  35. Europe Lutetium-177 Market By Region, From 2019-2024 ( USD Million )
  36. Europe Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  37. Europe Radium-223 Market By Region, From 2019-2024 ( USD Million )
  38. Europe Other Alpha Emitters Market By Region, From 2019-2024 ( USD Million )
  39. Europe Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  40. Europe Cesium-131 Market By Region, From 2019-2024 ( USD Million )
  41. Europe Iodine-125 Market By Region, From 2019-2024 ( USD Million )
  42. Europe Palladium-103 Market By Region, From 2019-2024 ( USD Million )
  43. Europe Iridium-192 Market By Region, From 2019-2024 ( USD Million )
  44. U.K Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  45. U.K Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  46. Spain Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  47. Spain Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  48. Germany Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  49. Germany Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  50. Italy Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  51. Italy Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  52. France Nuclear Medicine Radiopharmaceuticals Market By Type, From 2019-2024 (USD Million)
  53. France Nuclear Medicine Radiopharmaceuticals Market By Application, From 2019-2024 (USD Million)
  54. U.K Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  55. Spain Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  56. Germany Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  57. Italy Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  58. France Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  59. U.K SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  60. Spain SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  61. Germany SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  62. Italy SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  63. France SPECT Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  64. U.K PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  65. Spain PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  66. Germany PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  67. Italy PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  68. France PET Diagnostic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  69. U.K Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  70. Spain Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  71. Germany Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  72. Italy Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  73. France Therapeutic Radioisotopes Market By Type, From 2019-2024 ( USD Million )
  74. U.K Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  75. Spain Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  76. Germany Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  77. Italy Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  78. France Beta Emitters Market By Type, From 2019-2024 ( USD Million )
  79. U.K Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  80. Spain Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  81. Germany Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  82. Italy Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  83. France Alpha Emitters Market By Type, From 2019-2024 ( USD Million )
  84. U.K Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  85. Spain Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  86. Germany Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  87. Italy Brachytherapy Market By Type, From 2019-2024 ( USD Million )
  88. France Brachytherapy Market By Type, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample